Chromocell Therapeutics Corp. announced that its interim CEO Frank Knuettel, has been appointed as the Company?s permanent CEO. Mr. Knuettel was previously appointed Interim CEO in July 2023, while currently serving as the Company?s CFO, a role he will continue to fill for the near future.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 USD | -12.94% | -1.13% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 1.18Cr | |
+9.42% | 11TCr | |
+11.84% | 10TCr | |
-14.15% | 2.24TCr | |
-1.05% | 2.23TCr | |
-5.29% | 1.91TCr | |
-38.29% | 1.8TCr | |
-4.16% | 1.79TCr | |
+7.99% | 1.43TCr | |
+36.24% | 1.25TCr |
- Stock Market
- Equities
- CHRO Stock
- News Chromocell Therapeutics Corporation
- Chromocell Therapeutics Corp. Appoints Frank Knuettel, Interim CEO, as Permanent CEO